Betting on Rejuvenation: Global Capital Races Into a ‘Longevity’ Industry Where Expectations Outpace Science

The longevity industry, which aims to slow aging and extend healthy lifespans, is expanding rapidly. Longevity biotech companies and age-reversal technologies are drawing massive investment, while some are even claiming that aging can be treated or reversed. Yet much of the relevant technology remains in the validation stage, and the gap between the possibilities discussed in laboratories and the expectations being consumed in the market remains substantial.